Champions Oncology, Inc. Q2 FY2025 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2025 Q2 Call date: 2024-12-11 Concluded

Quarter scorecard

Revenue

$13.49M

+16.6% YoY

Diluted EPS

$0.05

Net income

$728,000

Pharmacology Services $12.50M

+14.9%

Product And Service Other $991,000

+42.2%

Translational Oncology Solutions TOS License Revenue $0